Bringing the fundamentals into focus…
Back to Standard BioTools Inc.
How Standard BioTools Inc. stacks up
LAB · against 287 other Healthcare companies of similar size
Profitability
22/ 100
Below the middle of the pack.
Ranked #199 of 288 · scores higher than 30% of peers
Bars: peers in each 10-point band of the profitability score37 peers with a profitability score of 20–29, including LAB · Click a bar to see the companies
Why profitability scores 22?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 88% of peers. Operating margin: -112.8% vs peer median 7.1%
- a lower return on invested capital: weaker than 82% of peers. Return on invested capital: -27.9% vs peer median 4.7%
- a higher return on assets: stronger than 94% of peers. Return on assets: 13.5% vs peer median 1.7%
Metric by metric
Position: dot = LAB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 248 reported | -27.9% | -1.3% | 26% | 33% | |
| Operating marginHigher is better · 268 reported | -112.8% | 1.9% | 20% | 33% | |
| Return on assetsHigher is better · 289 reported | 13.5% | -0.9% | 96% | 33% | |
| Return on equityHigher is better · 269 reported | -11.2% | -1.6% | 40% | Context only | |
| Gross marginHigher is better · 303 reported | 50.5% | 38.5% | 63% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around LAB| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 261M USD | 98 | 97 | |
| 3 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 3 | 356M AUD (≈$235M) | 97 | 81 | |
| 5 | 592M ILS (≈$160M) | 96 | 84 | |
| 195 | 7.1B TWD (≈$221M) | 23 | 25 | |
| 195 | 471M USD | 23 | 21 | |
| 195 | 469M USD | 23 | 50 | |
| 199 | 336M EUR (≈$369M) | 22 | 31 | |
| 199 | 239M USD | 22 | 38 | |
| 199 | 124M USD | 22 | 31 | |
| 199 | 394M USD | 22 | 37 | |
| 203 | 1.6B HKD (≈$209M) | 21 | 54 | |
| 203 | 365M USD | 21 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score